BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34875459)

  • 1. The many faces of intraperitoneal chemotherapy.
    Abdel Mageed H; Van Der Speeten K; Sugarbaker P
    Surg Oncol; 2022 Mar; 40():101676. PubMed ID: 34875459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.
    Kitai T
    Surg Today; 2021 Jul; 51(7):1085-1098. PubMed ID: 33185798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
    Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
    Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis.
    Repullo DJ; Barbois S; Leonard D; Bohlok A; Van den Audenaeren ET; Hendlisz A; Van den Eynde M; Donckier V; Kartheuser A; Liberale G
    Eur J Surg Oncol; 2021 Jul; 47(7):1661-1667. PubMed ID: 33602530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies.
    Klos D; Riško J; Stašek M; Loveček M; Hanuliak J; Skalický P; Lemstrová R; Mohelníková BD; Študentová H; Neoral Č; Melichar B
    Cas Lek Cesk; 2018 Dec; 157(8):419-428. PubMed ID: 30754979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal metastases from colorectal cancer in the Czech Republic in 2018.
    Němec L; Novák J; Mužík J; Krejčí D; Tomášek J; Šefr R; Bartoška P; Antoš F; Dytrych P; Hoskovec D; Levý M; Šimša J; Klos D; Neoral Č
    Klin Onkol; 2021; 34(4):278-282. PubMed ID: 34905928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Curr Oncol; 2020 Jun; 27(3):146-154. PubMed ID: 32669924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
    Scally CP; Fournier KF; Mansfield PF
    JAMA Surg; 2021 Mar; 156(3):e206364. PubMed ID: 33502464
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    López-Basave HN; Quiroz-Sandoval OA; Padilla-Rosciano AE; León-Takahashi AM; Miranda-Devora G; Arrollo-Monroy A
    Cir Cir; 2018; 86(3):277-284. PubMed ID: 29950734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
    Narasimhan V; Tan S; Kong J; Pham T; Michael M; Ramsay R; Warrier S; Heriot A
    Colorectal Dis; 2020 Nov; 22(11):1482-1495. PubMed ID: 32027455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application and prospect of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal metastasis from colorectal cancer].
    Zhou SC; Pei W; Zhou HT; Liang JW; Zhou ZX
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):73-78. PubMed ID: 35073651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the management of peritoneal surface malignancies - An evidence-based review.
    Ray MD; Dhall K
    Curr Probl Cancer; 2021 Dec; 45(6):100737. PubMed ID: 34116836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791).
    Kusamura S; Azmi N; Fumagalli L; Baratti D; Guaglio M; Cavalleri A; Garrone G; Battaglia L; Barretta F; Deraco M
    Eur J Surg Oncol; 2021 Jan; 47(1):82-88. PubMed ID: 31262599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience.
    Bartoş A; Bartoş D; Raluca S; Mitre C; Hadade A; Iancu I; Cioltean C; Iancu C; Militaru C; Părău A; Breazu C
    Chirurgia (Bucur); 2019; 114(2):222-233. PubMed ID: 31060655
    [No Abstract]   [Full Text] [Related]  

  • 20. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
    Arjona-Sanchez A; Aziz O; Passot G; Salti G; Esquivel J; Van der Speeten K; Piso P; Nedelcut DS; Sommariva A; Yonemura Y; Turaga K; Selvasekar CR; Rodriguez-Ortiz L; Sanchez-Hidalgo JM; Casado-Adam A; Rufian-Peña S; Briceño J; Glehen O
    Eur J Surg Oncol; 2021 Jun; 47(6):1420-1426. PubMed ID: 33298341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.